Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide G pseudogene 5 (SNRPGP5)

Target
SNRPGP5
Molecular classification
Pseudogene
01

Overview

SNRPGP5 (small nuclear ribonucleoprotein polypeptide G pseudogene 5) is classified as a pseudogene derived from a gene encoding a core protein of the spliceosomal small nuclear ribonucleoprotein (snRNP) complex, specifically the SNRPG protein. Pseudogenes such as SNRPGP5 typically do not produce functional proteins and are not considered biological drug targets, enzymes, receptors, or transporters. Functional snRNP proteins play critical roles in pre-mRNA splicing, but the pseudogene variants generally lack transcription or translation into biologically active proteins. There is no evidence that SNRPGP5 is involved in recognized biological functions, disease associations, drug interactions, or serves as a biomarker or therapeutic target. Additional context: While related snRNP proteins are involved in the assembly and function of the spliceosome (an essential cellular macromolecular complex that removes introns from pre-mRNA), pseudogenes themselves are genetically inactive remnants without biological activity or function in health or disease. Consequently, SNRPGP5 should not be considered a valid drug target or functionally relevant molecule for therapeutic development. If your intent was to ask about the functional SNRPG protein or another snRNP component, clarification or correction of the target name would be required to provide information relevant to drug targeting or signaling biology.

Other names
SNRPGP5
02

Mechanism of action

None (pseudogene)

03

Biological functions

None (pseudogenes do not encode functional proteins; ancestral locus for SNRPG, which is a core spliceosomal protein)
04

Disease associations

None for the pseudogene. However, functional SNRPG protein family members (not the pseudogene) are involved in spliceosome biology and may have relevance to disease through splicing defects.

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide G pseudogene 5 (SNRPGP5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 5 (SNRPGP5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call